TABLE 3.
Codons at which differences exist between subtype B and non-B viruses
| Region | Amino acid position | Wild-type codon in subtype Ba | Amino acid | Subtype(s) | Wild-type codon in non- subtype B | Amino acidb | Mutated codonc | Resistant amino acid | Drugs affectedd |
|---|---|---|---|---|---|---|---|---|---|
| RT | 106 | GTA | V | C | GTG | V | ATGe | M | EFV, NVP, DLV |
| 108 | GTA | V | G | GTG | V | ATA | I | EFV, NVP | |
| 179 | GTT | V | G, A/G | GTG | V | GAG or GAA | E | EFV, NVP, DLV | |
| 179 | GTT | V | A | ATT | I | GAT or GAC | D | EFV, DLV | |
| PR | 20 | AAG | K | A, A/E | AAA | K | ATG | M | IDV, RTV, LPV, ATZ, TPV |
| 82 | GTC | V | G | ATC | I | GCC | A | Multi-PI | |
| 82 | GTC | V | G | ATC | I | TCC or AGC | S | Multi-PI | |
| 82 | GTC | V | G | ATC | I | ACC | T | Multi-PI |
The underlined nucleotides represent transitions or transversions from wild type to nucleotides that code for a resistance-associated amino acid.
Presumed polymorphism.
Nucleotides that encode resistance-associated amino acids.
Abbreviations: DLV, delevaridine; IDV, indinavir; RTV, ritonavir; LPV, lopinavir; ATZ, atazanavir; TPV, tipranavir.
Differences in numbers of nucleotide changes needed to mutate a particular drug resistance-associated amino acid. Only frequently observed mutations are shown.